WallStreetZenWallStreetZen

NASDAQ: INCR
Intercure Ltd Stock Ownership - Who owns Intercure?

Insider buying vs selling

Have Intercure Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INCR insiders and whales buy or sell their stock.

INCR Shareholders

What type of owners hold Intercure Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ibex Investors LLC4.15%1,889,658$4.61MInstitution
Mirae Asset Global Investments Co Ltd1.48%672,982$1.64MInstitution
Tidal Investments LLC0.71%325,741$794.81kInstitution
Healthcare Of Ontario Pension Plan Trust Fund0.47%212,500$518.50kInstitution
Moore Capital Management LP0.21%97,273$237.35kInstitution
Jpmorgan Chase Co0.17%75,750$184.83kInstitution
Bank Of America Corp0.15%69,209$168.87kInstitution
Cambria Investment Management LP0.12%54,681$133.42kInstitution
Citadel Advisors LLC0.10%43,741$106.73kInstitution
Renaissance Technologies LLC0.08%34,600$84.42kInstitution

1 of 2

INCR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCR7.74%0.00%
DERM9.06%36.30%Net BuyingNet Buying
ASRT45.93%20.73%Net SellingNet Selling
ETON27.96%21.84%
SCYX39.19%21.69%Net Selling

Intercure Stock Ownership FAQ

Who owns Intercure?

Intercure (NASDAQ: INCR) is owned by 7.74% institutional shareholders, 0.00% Intercure insiders, and 92.26% retail investors. Ibex Investors LLC is the largest individual Intercure shareholder, owning 1.89M shares representing 4.15% of the company. Ibex Investors LLC's Intercure shares are currently valued at $4.33M.

If you're new to stock investing, here's how to buy Intercure stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.